Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;103:e10-e11
doi: 10.1161/CIRCRESAHA.108.178673
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mattiazzi, A.
Right arrow Articles by Mundiña-Weilenmann, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mattiazzi, A.
Right arrow Articles by Mundiña-Weilenmann, C.
(Circulation Research. 2008;103:e10.)
© 2008 American Heart Association, Inc.


Letters to the Editor

Ca2+-Calmodulin–Dependent Protein Kinase Phosphorylation of Ryanodine Receptor May Contribute to the β-Adrenergic Regulation of Myocardial Contractility Independently of Increases in Heart Rate

Alicia Mattiazzi, Leticia Vittone, Cecilia Mundiña-Weilenmann

Centro de Investigaciones Cardiovasculares, Facultad de Ciencias Médicas, Universidad Nacional de La Plata, La Plata, Argentina, E-mail ramattia@atlas.med.unlp.edu.ar


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

To the Editor:

In a recent article, MacDonnell et al1 reported that protein kinase A (PKA) phosphorylation of ryanodine receptor (RyR2) (the Ca2+ release channel of the sarcoplasmic reticulum [SR]) at Ser2808/09 site does not have a major role in the sympathetic nervous system (SNS) regulation of cardiac function. This conclusion was based on comparing the effect of isoproterenol on ventricular performance, in vivo, in isolated hearts and myocytes, in wild-type mice and in a genetically modified mouse in which Ser2808 of RyR2 was replaced by alanine (S2808A) to prevent PKA-mediated phosphorylation at this site. Isoproterenol produced an increase in cardiac function both in vivo and in isolated hearts, as well as an enhancement in the L-type Ca2+ current (ICaL), the amplitude of the Ca2+ transient and the excitation–contraction coupling (ECC) gain in isolated myocytes, which were not significantly different between wild-type and S2808A mice.

We have previously demonstrated the lack of functionality of the PKA-dependent phosphorylation of RyR2 at Ser2808/09.2 In perfused rat hearts, we showed that the isoproterenol-induced phosphorylation of RyR2 was associated with an enhancement of the [3H]-ryanodine binding and the velocity of fast Ca2+ release in SR vesicles from the same hearts. This increase in RyR2 activity, however, was not attributable to the PKA-dependent phosphorylation at Ser2809 site. Therefore, the results by MacDonnell et al are in full agreement with our previous findings and confirm in genetically manipulated mice the lack of functionality of the RyR2 Ser 2808/09 site.

The purpose of our . . . [Full Text of this Article]